NEUmiRNA Therapeutics
Biotechnology company developing microRNA-based therapeutics for neurodegenerative and other diseases, leveraging proprietary miRNA platform technology.
Website
https://www.neumirna.comLocation
Netherlands
Founded
2018
Investors
1
Categories
biotech, therapeutics, mirna, rna-therapeutics
Notes
NEUmiRNA Therapeutics is a biotechnology company focused on developing microRNA (miRNA)-based therapeutics. The company's proprietary platform enables the development of miRNA modulators for treating various diseases, with a focus on neurodegenerative conditions.
MicroRNAs are small non-coding RNA molecules that regulate gene expression, and modulating specific miRNAs offers a novel approach to treating diseases at the genetic level.
Team
- Leadership team information not publicly available
Additional Research Findings
- Portfolio company of Angelini Ventures (2024)
- Focus on miRNA therapeutics for disease treatment
- Proprietary miRNA platform technology
- Targeting neurodegenerative diseases and other conditions
- Part of the growing RNA therapeutics space
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Angelini Ventures | Rome, Italy | cvc | seedseries-a+2 | 4 |